New obesity procedure also reduces muscle mass

A study about a new procedure for the treatment of obesity has raised some concerns. This is because, while the treatment leads to weight loss, the pounds a person sheds consist of skeletal muscle as well as fat. Also, body fat loss seems to be mainly of the subcutaneous type. Skeletal muscle is necessary for good health; its loss can result in not only physical problems, but it can also impair metabolism and raise the risk of injury. Visceral fat is the type of fat that surrounds the organs deep inside the abdomen. Doctors have linked carrying too much of it to health problems, such as type 2 diabetes and heart disease. The procedure is called left gastric artery embolization. Interventional radiologists have been using it for decades to stop bleeding in emergencies. However, the idea of using gastric artery embolization to treat obesity is new, and clinical trials are currently evaluating its safety and effectiveness for such a purpose. The aim of the treatment is to reduce the effect of an appetite hormone by injecting microscopic beads to block an artery that supplies blood to the stomach. The study's findings featured recently at the annual meeting of the Radiological Society of North America that is currently taking place in Chicago, IL.